Ledifos Tablets has undergone numerous clinical trials and is approved for the treatment of patients with 1 and 4 genotypes of the virus. The research results showed that the chances of recovery start from 95% and reach 100% of the value with the correct course of therapy.
The drug does not require combinations with other drugs, and, due to low toxicity, has a minimum of side effects, the most difficult of which will be a feeling of fatigue, and, perhaps, mild headache. No more ribavirin and interferon - this poison can be safely thrown into the trash.
